JK Pharmachem Limited is a member of JK organization which is among the top business houses in india. It manufactures fermentation based products. JK drugs and pharmaceuticals limited (JKDPL) is another unit manufactures intermediates, bulk actives and formulations. The ranges includes various cephalosporins and other therapeutic areas.

JKPL commissioned the Penicilin-G plant with a capital outlay of Rs. 1950 million in a record time of 19 months. The plant is build in accordance with the latest GMP/FDA standards. The manufacturing activity is based on systems approach with complete automation and microprocessor control. JKPL has mastered the complex fermentation technology in a short span and has made rapid progress during the last 3 years. Currently JKPL operates above 100% capacity with a market share of more than 25% in the Indian market.

R & D - Quest for Excellence At JKPL the thrust is on continuous development. More than 50 highly qualified technical personnel work in the research and development team. The team focuses on:
* Upgradation of fermentation technology
* Strain improvement
* Processed improvement
* New Biotechnology products.